AZN icon

AstraZeneca

1,138 hedge funds and large institutions have $33.8B invested in AstraZeneca in 2024 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 485 increasing their positions, 340 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

0.45% less ownership

Funds ownership: 32.57%32.12% (-0.45%)

1% less capital invested

Capital invested by funds: $34B → $33.8B (-$235M)

8% less funds holding in top 10

Funds holding in top 10: 1312 (-1)

Holders
1,138
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$480M
Puts
$470M
Net Calls
Net Calls Change

Top Sellers

1 -$903M
2 -$659M
3 -$157M
4
N
Nuveen
North Carolina
-$129M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$103M
Name Holding Trade Value Shares
Change
Change in
Stake
726
$359K
727
$354K
728
$352K
729
$351K
730
$351K
731
$350K
732
$349K
733
$349K
734
$344K
735
$342K
736
$342K
737
$339K
738
$339K
739
$339K
740
$339K
741
$335K
742
$334K
743
$334K
744
$333K
745
$331K
746
$330K
747
$330K
748
$327K
749
$327K
750
$325K